Immuno-Oncology Enhances Battlespace Awareness – Genetic Engineering & Biotechnology News
|
Immuno-Oncology Enhances Battlespace Awareness
Genetic Engineering & Biotechnology News Still, cancer cells often evade immune surveillance, as demonstrated by cancers that develop to the point of being clinically recognized, notes Lance Leopold, M.D., the group vice president for immuno-oncology development at Incyte. Scientists are now … |
